241 related articles for article (PubMed ID: 24610925)
1. HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.
Zewinger S; Speer T; Kleber ME; Scharnagl H; Woitas R; Lepper PM; Pfahler K; Seiler S; Heine GH; März W; Silbernagel G; Fliser D
J Am Soc Nephrol; 2014 May; 25(5):1073-82. PubMed ID: 24610925
[TBL] [Abstract][Full Text] [Related]
2. Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging.
Peralta CA; Lee A; Odden MC; Lopez L; Zeki Al Hazzouri A; Neuhaus J; Haan MN
J Am Geriatr Soc; 2013 Jan; 61(1):90-5. PubMed ID: 23252993
[TBL] [Abstract][Full Text] [Related]
3. Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Tomaschitz A; Pilz S; Ritz E; Grammer T; Drechsler C; Boehm BO; März W
Am J Kidney Dis; 2011 Mar; 57(3):403-14. PubMed ID: 21186074
[TBL] [Abstract][Full Text] [Related]
4. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.
Steubl D; Schneider MP; Meiselbach H; Nadal J; Schmid MC; Saritas T; Krane V; Sommerer C; Baid-Agrawal S; Voelkl J; Kotsis F; Köttgen A; Eckardt KU; Scherberich JE;
Clin J Am Soc Nephrol; 2020 May; 15(5):616-624. PubMed ID: 32291270
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of serial decline of kidney function to predict mortality and cardiovascular events in patients undergoing coronary angiography.
Rein P; Saely CH; Vonbank A; Boehnel C; Drexel H
Am J Cardiol; 2014 Jan; 113(2):215-21. PubMed ID: 24169005
[TBL] [Abstract][Full Text] [Related]
6. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
[TBL] [Abstract][Full Text] [Related]
7. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
[TBL] [Abstract][Full Text] [Related]
8. There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3-5.
Chiu H; Wu PY; Huang JC; Tu HP; Lin MY; Chen SC; Chang JM
Sci Rep; 2020 Jul; 10(1):12749. PubMed ID: 32728174
[TBL] [Abstract][Full Text] [Related]
9. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
[TBL] [Abstract][Full Text] [Related]
11. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
[TBL] [Abstract][Full Text] [Related]
12. Copeptin Associates with Cause-Specific Mortality in Patients with Impaired Renal Function: Results from the LURIC and the 4D Study.
Krane V; Genser B; Kleber ME; Drechsler C; März W; Delgado G; Allolio B; Wanner C; Fenske W;
Clin Chem; 2017 May; 63(5):997-1007. PubMed ID: 28280053
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease predicts coronary plaque vulnerability: an optical coherence tomography study.
Dai J; Xing L; Hou J; Jia H; Hu S; Tian J; Lin L; Li L; Zhu Y; Zheng G; Zhang S; Yu B; Jang IK
Coron Artery Dis; 2017 Mar; 28(2):135-144. PubMed ID: 27922522
[TBL] [Abstract][Full Text] [Related]
14. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
[TBL] [Abstract][Full Text] [Related]
15. Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis.
Kawachi K; Kataoka H; Manabe S; Mochizuki T; Nitta K
Heart Vessels; 2019 Sep; 34(9):1440-1455. PubMed ID: 30874893
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C as a predictor of mortality in elderly patients with chronic kidney disease.
Bevc S; Hojs N; Knehtl M; Ekart R; Hojs R
Aging Male; 2019 Mar; 22(1):62-67. PubMed ID: 29912597
[TBL] [Abstract][Full Text] [Related]
17. Kidney function and mortality in octogenarians: Cardiovascular Health Study All Stars.
Shastri S; Katz R; Rifkin DE; Fried LF; Odden MC; Peralta CA; Chonchol M; Siscovick D; Shlipak MG; Newman AB; Sarnak MJ
J Am Geriatr Soc; 2012 Jul; 60(7):1201-7. PubMed ID: 22724391
[TBL] [Abstract][Full Text] [Related]
18. Serum Calcification Propensity and Clinical Events in CKD.
Bundy JD; Cai X; Mehta RC; Scialla JJ; de Boer IH; Hsu CY; Go AS; Dobre MA; Chen J; Rao PS; Leonard MB; Lash JP; Block GA; Townsend RR; Feldman HI; Smith ER; Pasch A; Isakova T;
Clin J Am Soc Nephrol; 2019 Nov; 14(11):1562-1571. PubMed ID: 31658949
[TBL] [Abstract][Full Text] [Related]
19. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
Poesen R; Ramezani A; Claes K; Augustijns P; Kuypers D; Barrows IR; Muralidharan J; Evenepoel P; Meijers B; Raj DS
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1525-33. PubMed ID: 26153127
[TBL] [Abstract][Full Text] [Related]
20. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
